PRAX - Praxis Ionis stocks dip in wake of Praxis drug updates
2023-10-02 14:25:11 ET
More on Praxis Precision Medicines
- Praxis Precision Medicines: Long List Of Failures And Mixed Data
- Praxis Precision Meds up 9% on new Truist buy rating
- Larimar, Design higher as they benefit from Biogen deal for Reata
- Seeking Alpha’s Quant Rating on Praxis Precision Medicines
- Historical earnings data for Praxis Precision Medicines
For further details see:
Praxis, Ionis stocks dip in wake of Praxis drug updates